May 6, 2022

Press release

FluoGuide invites to presentation of FG001 results from the first clinical trial in aggressive brain cancer on 17 May 2022

Copenhagen, Denmark, 6 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) invites to a presentation of the results from the... [Read more]

May 2, 2022

Press release

Annual General Meeting Copenhagen, Denmark, 2 May 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) hereby convenes an annual general meeting to be held on 18 May 2022.

To the shareholders of FluoGuide A/S The board of directors hereby convenes an annual general meeting of FluoGuide to be held... [Read more]

April 1, 2022

Press release

FluoGuide announces positive top line result from the first part of the ongoing clinical phase I/II trial testing the safety and performance of FG001 in lightening up aggressive brain cancer

Copenhagen, Denmark, 01.04.2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that FG001 has been shown safe and... [Read more]

March 30, 2022

Press release

FluoGuide A/S publishes Year-end and annual report for the fiscal year 2021

Copenhagen, Denmark, 30 March 2022  – FluoGuide A/S (“FluoGuide” or the “Company”) hereby publishes its annual report for the fiscal year... [Read more]

March 29, 2022

Press release

FluoGuide A/S issue warrants to employees and management

Copenhagen, Denmark, 29 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that based on the approved... [Read more]

March 24, 2022

Press release

FluoGuide has received approval from the Danish Medicines Agency to initiate phase II trial with FG001 in lung cancer

Copenhagen, Denmark, 24 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is delighted to announce that the company has received... [Read more]

March 18, 2022

Press release

FluoGuide has been awarded a grant together with Rigshospitalet (DK) to conduct a phase II trial with FG001 in patients with less aggressive brain cancers

Copenhagen, Denmark, 18 March 2022 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce a grant of total 945... [Read more]

March 17, 2022

Press release

In connection with the Directed Share Issue dated the 10 of March 2022, Life Science ApS have agreed to lend 142,000 shares to ABG Sundal Collier AB in order to facilitate delivery of the shares.

Copenhagen, Denmark, 17 March 2022 – FluoGuide A/S (publ) a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”)... [Read more]

March 10, 2022

Press release

FluoGuide has completed a directed share issue raising approximately SEK 25 million

Copenhagen, Denmark, 10 March 2022 – FluoGuide A/S (publ) a developer of surgical precision solutions within oncology (“FluoGuide” or the “Company”)... [Read more]